Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Parallel-Group Study to Assess the Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With Multiple Sclerosis
Conditions
Interventions
arbaclofen ER Tablets
Placebo for arbaclofen ER tablets
Locations
2
United States
Advance Medical Pain Management & Research Clinic
Miami, Florida, United States
Meridien Research
Tampa, Florida, United States
Start Date
July 1, 2016
Primary Completion Date
October 1, 2018
Completion Date
January 1, 2019
Last Updated
April 27, 2022
NCT07325292
NCT07542626
NCT05748015
NCT07504575
NCT06433765
NCT04876339
Lead Sponsor
RVL Pharmaceuticals, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions